AzTrials
AzTrials

AgingNCT06618469

Effects of Resistance Training Programes At Different Intensities on Musculoskeletal, Metabolic, Lipid, Immunological, Inflammatory, Well-being and Functional Parameters in Older Adults.

A study testing Elastic band-based resistance training program at high intensity (HI), Elastic band-based resistance training program at moderate-high intensity (MHI-bands) and Elastic band-based resistance training program at moderate intensity (MI) in people with Aging, run by University of Valencia at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aging of the global population is recognized by the World Health Organization (WHO) as a major issue due to the disabilities and comorbidities related to this process, with women being the gender most affected. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Aging
What is being tested?
Elastic band-based resistance training program at high intensity (HI), Elastic band-based resistance training program at moderate-high intensity (MHI-bands) and Elastic band-based resistance training program at moderate intensity (MI)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
320 participants
Where
1 siteSpain
Study dates
May 2014to Jul 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age \> 60 years
  • Physically independent (able to walk 100 m without a walking aid and climb 10 steps without rest)
  • On the registration waiting list for physical activity at their respective Municipal Activity Centers for Older People (MACOP).
  • Sedentary lifestyle (less than one hour of physical activity or exercise a week during the previous six months).
  • Medical certificate of suitability or fitness to practice resistance training activities.
  • No plans to leave the area during the intervention.
  • Cognitive ability to understand and follow the instructions and sign the informed consent form.
  • Free of any antioxidant supplements for at least six weeks before the start of this study.

Who cannot join

  • Presence of cardiovascular, musculoskeletal, renal, liver, pulmonary, or neuromuscular and neurological disorders that would prevent the participant from performing the exercises.
  • Current or prior (past six months) use of hormone replacement therapy.
  • Body weight changes \> 10% in the previous year.
  • Intake of prescription medications or supplements (e.g., vitamins C, E) that were expected to alter the results of the study (ergogenic, dietary aids, estrogen, beta-blockers, steroid hormones, calcitonin, corticosteroids, glucocorticoids, thiazide diuretics, anticonvulsants, bisphosphonates, raloxifene).
  • A history of malignant neoplasms.
  • Terminal illness with life expectancy of less than one year.
Show all 10Show fewer
  • Engagement in regular strength training (more than once a week) during the previous six months.
  • Participation in another research project (within the last six months) involving dietary, exercise, and/or pharmaceutical intervention.
  • Mini mental State Examination lower than 23/30.
  • Severe visual or hearing impairment.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Physical activity and Sport Science Faculty

    Valencia, Valencia, 46020

Other trials in Spain

About this study

The aging of the global population is recognized by the World Health Organization (WHO) as a major issue due to the disabilities and comorbidities related to this process, with women being the gender most affected. Due to the physiological and psychological age associated declines, physical activity and exercise are proven strategies for reducing the impact of aging. However, it is still unknown what kind of training program could be the most effective in reversing deleterious age-related changes in older adults. Regarding this, the type of training intensity and exercise modality are two key training parameters in exercise programming, and, therefore, different adaptations could be induced in older adults through the modification of these parameters. Furthermore, the type of training device is a significant factor and can act as a barrier or facilitator in older adults\' participation in physical activities and exercise programs. Therefore, the research project primary goals are to compare the effects of resistance training programes performed at different intensities and materials during 32 weeks on a variety of physiological parameters in older adults.

Read the detailed description

This is a randomized clinical trial (RCT) with 6 parallel arms. The subjects will be divided in 6 groups with a randomized technique assigned to a 32-week of: a) progressive elastic band-based resistance training program at high intensity (HI); b) progressive elastic band-based resistance training program at moderate-high intensity (MHI-bands); c) progressive elastic band-based resistance training program at moderate intensity (MI); d) progressive elastic tubes-based resistance training program at moderate-high intensity (MHI-tubes); e) progressive water-resistance training program at moderate intensity (WMI); f) self-management control group (CG). The subjects will be submitted to a 2-session familiarization period and then a 32-week of training program will be performed twice a week.

The exercise groups engaged in progressive elastic-based (bands of tubes) resistance training twice a week with three to four sets of six (HI), 10 (MHI) or 15 (MI) submaximal repetitions including six overall body exercises at a rate of perceived exertion (RPE) of 6-7 in the first four weeks and 8-9 in the remaining weeks on the OMNI-Resistance Exercise Scale (RES). The water-resistance group will perform similar exercises adapted to the water environment at maximal effort (maximal speed in the concentric and eccentric phases of each repetition) during 40 seconds. Members of the control group were instructed to continue their everyday lives.

Oxidative stress, bone health, body composition, neuromuscular strength, physical function, quality of life, lipidic, immune and cardiometabolic profile will be assessed. Oxidative stress status will be assessed in deoxyribonucleic acid (DNA) (urinary 8-oxo-2-deoxyguanosine [8-oxo-dG], lipids (F2-isoprostanes[8-iso-P]; malonaldehyde [MDA], and proteins (protein carbonyls) products together with antioxidant enzymes (superoxide dismutase [SOD] and glutathione peroxidase [GPx]), and thiol redox state (reduced glutathione [GSH], oxidized glutathione [GSSG], and the GSSG/GSH ratio. Bone health will be integrated by measures of areal bone mineral density (aBMD) and the T-score of the lumbar spine (L1-L4 segments, L2-L4 segments, and L1, L2, L3, and L4 individual vertebrae) and proximal femur (femoral neck, trochanter, intertrochanter, Ward\'s triangle, and total hip in both projects) will be assessed by dual-energy X-ray absorptiometry (DXA). Additionally bone health will be also composed by fracture risk (the 10-year probability of a major osteoporotic fracture and the 10-year probability of a hip fracture), bone turnover markers (BTMs) of bone formation (procollagen type I N propeptide [P1NP], a bone-specific isoform of alkaline phosphatase [bALP]) and bone resorption (a β-isomerized form of C-terminal telopeptide of type I collagen [β-CTx]), and their relationship (bALP/ β-CTx ratio). Body composition (total body mass, total fat mass, total fat-free mass, and total body fat percentage) will be measured by DXA. Moreover, the neuromuscular strength of upper limbs (elbow flexor and extensor muscles) and lower limbs (hip abductor and hip adductor along with knee flexor and extensor muscles) will be assessed through isokinetic dynamometry at low (60°/s) and high (180°/s) velocities. Finally, physical performance will be measured using various functional tests and batteries widely used in the literature, such as the 30 seconds chair stand (30sec-CS) and 30 seconds arm curl (30sec-AC) for muscle strength/endurance of the lower and upper limbs; time up and go (TUG) for dynamic balance/agility; the six-minute walking test (6MWT) for aerobic endurance; five sit-to stand.

Conditions
Aging
Being tested
Elastic band-based resistance training program at high intensity (HI), Elastic band-based resistance training program at moderate-high intensity (MHI-bands), Elastic band-based resistance training program at moderate intensity (MI), Elastic tubes-based resistance training program at moderate-high intensity (MHI-tubes), Water-based resistance training program at moderate intensity (WMI)
Keywords
Aging, Dose-response, Exercise intensities, Oxidative stress, Physical activity, Bone health, Neuromuscular physiology
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Elastic band-based resistance training program at high intensity (HI)Behavioural

    Also called 1

    The training session will consist of 5-10 minutes of general warm-up (joint- mobility and aerobic exercises at low intensity); 35-40 minutes of the main part, which comprised six resistance exercises, three for upper limbs (upright rowing, incline rowing, and elbow curl) and three for lower limbs (narrow stance squat, lunge, and standing hip abduction) along with coordination exercises during the active rests; and 5-10 minutes of the cool-down routine (respiratory and flexibility exercises). The participants will perform 6 submaximal repetitions using elastic bands equivalent to 85% of the one-repetition maximum per exercise (high load/intensity training sessions). The perceived exertion level on the OMNI-RES scale progressed from 6-7 to 8-9 . The number of sets per exercise progressed from 3 to 4. The speed of execution of the exercises was controlled using a metronome marking the cadence (2s of concentric and eccentric phase).

  • Elastic band-based resistance training program at moderate-high intensity (MHI-bands)Behavioural

    Also called 2

    The training session will consist of 5-10 minutes of general warm-up (joint- mobility and aerobic exercises at low intensity); 35-40 minutes of the main part, which comprised six resistance exercises, three for upper limbs (upright rowing, incline rowing, and elbow curl) and three for lower limbs (narrow stance squat, lunge, and standing hip abduction) along with coordination exercises during the active rests; and 5-10 minutes of the cool-down routine (respiratory and flexibility exercises). The participants will perform 6 submaximal repetitions using elastic bands equivalent to 75-80% of the one-repetition maximum per exercise (high to moderate load/intensity training sessions). The perceived exertion level on the OMNI-RES scale progressed from 6-7 to 8-9 . The number of sets per exercise progressed from 3 to 4. The speed of execution of the exercises was controlled using a metronome marking the cadence (2s of concentric and eccentric phase).

  • Elastic band-based resistance training program at moderate intensity (MI)Behavioural

    Also called 3

    The training session will consist of 5-10 minutes of general warm-up (joint- mobility and aerobic exercises at low intensity); 35-40 minutes of the main part, which comprised six resistance exercises, three for upper limbs (upright rowing, incline rowing, and elbow curl) and three for lower limbs (narrow stance squat, lunge, and standing hip abduction) along with coordination exercises during the active rests; and 5-10 minutes of the cool-down routine (respiratory and flexibility exercises). The participants will perform 6 submaximal repetitions using elastic bands equivalent to 65-70% of the one-repetition maximum per exercise (moderate load/intensity training sessions). The perceived exertion level on the OMNI-RES scale progressed from 6-7 to 8-9. The number of sets per exercise progressed from 3 to 4. The speed of execution of the exercises was controlled using a metronome marking the cadence (2s of concentric and eccentric phase).

  • Elastic tubes-based resistance training program at moderate-high intensity (MHI-tubes)Behavioural

    Also called 4

    The training session will consist of 5-10 minutes of general warm-up (joint- mobility and aerobic exercises at low intensity); 35-40 minutes of the main part, which comprised six resistance exercises, three for upper limbs (upright rowing, incline rowing, and elbow curl) and three for lower limbs (narrow stance squat, lunge, and standing hip abduction) along with coordination exercises during the active rests; and 5-10 minutes of the cool-down routine (respiratory and flexibility exercises). The participants will perform 6 submaximal repetitions using elastic tubes equivalent to 75-80% of the one-repetition maximum per exercise (high to moderate load/intensity training sessions). The perceived exertion level on the OMNI-RES scale progressed from 6-7 to 8-9 . The number of sets per exercise progressed from 3 to 4. The speed of execution of the exercises was controlled using a metronome marking the cadence (2s of concentric and eccentric phase)

  • Water-based resistance training program at moderate intensity (WMI)Behavioural

    Also called 5

    The training session will consist of 5-10 minutes of general warm-up (joint- mobility and aerobic exercises at low intensity); 35-40 minutes of the main part, which comprised six resistance exercises, three for upper limbs (upright rowing, incline rowing, and elbow curl) and three for lower limbs (narrow stance leg extension and flexion, hip flexion and extension, and standing hip abduction) along with coordination exercises during the active rests; and 5-10 minutes of the cool-down routine (respiratory and flexibility exercises). The participants will perform in the poll the concentric and eccentric movements of each exercise at maximal velocity during 40 seconds (equivalent to working around 10 repetitions /75% 1RM each exercise). The perceived exertion level on the OMNI-RES scale progressed from 6-7 to 8-9. The number of sets per exercise progressed from 3 to 4.

Study groups in NCT06618469
Study groupRoleWhat they receive
Elastic band-based resistance training program at high intensity (HI)ExperimentalNot described
Receives: Behavioral: Elastic band-based resistance training program at high intensity (HI)
Elastic band-based resistance training program at moderate-high intensity (MHI-bands)ExperimentalNot described
Receives: Behavioral: Elastic band-based resistance training program at moderate-high intensity (MHI-bands)
Elastic band-based resistance training program at moderate intensity (MI)ExperimentalNot described
Receives: Behavioral: Elastic band-based resistance training program at moderate intensity (MI)
Elastic tubes-based resistance training program at moderate-high intensity (MHI-tubes)ExperimentalNot described
Receives: Behavioral: Elastic tubes-based resistance training program at moderate-high intensity (MHI-tubes)
Water-based resistance training program at moderate intensity (WMI)ExperimentalNot described
Receives: Behavioral: Water-based resistance training program at moderate intensity (WMI)
Control groupNo interventionParticipants randomized into the CONTROL group will not undertake any formal intervention and will be asked to maintain their usual physical activity habits and diet.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in DNA oxidative stress

    The oxidative stress of DNA will be assessed via urine collections of 8-oxo-7,8- dihydro-20-deoxyguanosine (8-OHdG) in nmol/mmol creatinine.

    Measured: Baseline and 16 weeks

  2. Change in lipid peroxidation

    The lipid peroxidation will be assessed via urine and blood collections of 8-isoprostane(nmol /mmol creatinine) and Malondialdehyde (μmol/L)

    Measured: Baseline and 16 weeks

  3. Change in protein oxidation

    The protein oxidation will be assessed via blood collections of protein carbonyl (nmol/L)

    Measured: Baseline and 16 weeks

  4. Change in antioxidants enzymes-Superoxid dismutase

    The antioxidants enzymes will be assessed via blood collections of superoxid dismutase (U · mL-1)

    Measured: Baseline and 16 weeks

  5. Change in antioxidants enzymes-reduced glutathione

    The antioxidants enzymes will be assessed via blood collections of reduced glutathione (nmol/mg protein)

    Measured: Baseline and 16 weeks

  6. Change in antioxidants enzymes- Glutathione peroxidase

    The antioxidants enzymes will be assessed via blood collections of glutathione peroxidase (IU/g Hb).

    Measured: Baseline and 16 weeks

  7. Change in antioxidants enzymes-oxidized glutathione

    The antioxidants enzymes will be assessed via blood collections of oxidized glutathione (nmol/mg protein).

    Measured: Baseline and 16 weeks

  8. Change in antioxidants enzymes-Catalase

    The antioxidants enzymes will be assessed via blood collections of catalase (IU/g Hb).

    Measured: Baseline and 16 weeks

Secondary outcomes (22)
  1. Change in inflammatory profile

    The C-reactive protein (mg/L) and interleukin 6 (IL-6) will be assessed via blood collections.

    Measured: Baseline, 16 and 32 weeks

  2. Change in renal and hepatic profile

    Glutamic-pyruvic transaminase (GPT), glutamic-oxaloacetic transaminase (GOT); gamma-glutamyl transpeptidase (GCT) and alkaline phosphatase (ALP) will be measured.

    Measured: Baseline, 16 and 32 weeks

  3. Change in metabolic profile-glycosylated hemoglobin A1C

    The metabolic profile will be assessed via blood collections of glycosylated hemoglobin A1C (%).

    Measured: Baseline, 16 and 32 weeks

  4. Change in metabolic profile-basal glucose

    The metabolic profile will be assessed via blood collections of basal glucose (mmol/l).

    Measured: Baseline, 16 and 32weeks

  5. Change in immune profile-Platelet counts

    The immune profile will be assessed via blood collections of platelet counts (10*9/L).

    Measured: Baseline, 16 and 32 weeks

  6. Change in immune profile-plateletcrit

    The immune profile will be assessed via blood collections of plateletcrit (%)

    Measured: Baseline, 16 and 32 weeks

  7. Change in immune profile-mean platelet volum

    The immune profile will be assessed via blood collections of mean platelet volum (fl).

    Measured: Baseline, 16 and 32 weeks

  8. Change in immune profile-platelet distribution width

    The immune profile will be assessed via blood collections of platelet distribution width (%).

    Measured: Baseline, 16 and 32 weeks

  9. Change in immune profile-leukocites

    The immune profile will be assessed via blood collections of platelet counts leukocytes (% and 10*9/L).

    Measured: Baseline, 16 and 32 weeks

  10. Change in immune profile- neutrophils

    The immune profile will be assessed via blood collections of neutrophils (% and 10*9/L).

    Measured: Baseline, 16 and 32 weeks

  11. Change in immune profile-lymphocytes

    The immune profile will be assessed via blood collections of lymphocytes (% and 10*9/L).

    Measured: Baseline, 16 and 32 weeks

  12. Change in immune profile-monocytes

    The immune profile will be assessed via blood collections of monocytes (% and 10*9/L).

    Measured: Baseline, 16 and 32 weeks

  13. Change in immune profile-eosinophils

    The immune profile will be assessed via blood collections of eosinophils (% and 10*9/L).

    Measured: Baseline, 16 and 32 weeks

  14. Change in immune profile-basophils

    The immune profile will be assessed via blood collections of basophils (% and 10*9/L).

    Measured: Baseline, 16 and 32 weeks

  15. Change in lipid profile-total cholesterol

    The lipid profile will be assessed via blood collections: total cholesterol (mg/dL)

    Measured: Baseline, 16 and 32 weeks

  16. Change in lipid profile-high-density lipoprotein cholesterol

    The lipid profile will be assessed via blood collections: high-density lipoprotein cholesterol (mg/dL).

    Measured: Baseline, 16 and 32 weeks

  17. Change in lipid profile-low-density lipoprotein cholesterol

    The lipid profile will be assessed via blood collections: low-density lipoprotein cholesterol (mg/dL)

    Measured: Baseline, 16 and 32 weeks

  18. Change in lipid profile-triglycerides

    The lipid profile will be assessed via blood collections triglycerides (mg/dL)

    Measured: Baseline, 16 and 32 weeks

  19. Change in lipid profile-apolipoprotein B/apolipoprotein A

    The lipid profile will be assessed via blood collections: apolipoprotein B/apolipoprotein A (ApoB/ApoA) ratio

    Measured: Baseline, 16 and 32 weeks

  20. Change in bone metabolism - Type I procollagen N-terminal propeptide (Bone formation)

    The bone metabolism will be assessed via blood collections of Type I procollagen N-terminal propeptide (P1NP).

    Measured: Baseline, 16 and 32 weeks

  21. Change in bone metabolism - Bone alkaline phosphatase (Bone formation)

    The bone metabolism will be assessed via blood collections of bone alkaline phosphatase which are markers marker of bone formation.

    Measured: Baseline, 16 and 32 weeks

  22. Change in bone metabolism - terminal telopeptide of collagen type I (bone resorption)

    The bone metabolism will be assessed via blood collections of terminal telopeptide of collagen type I (β-CTX- 1) which is a marker of bone resorption.

    Measured: Baseline, 16 and 32 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2024
  2. Study startMay 2014
  3. Primary completionJul 2015
  4. Study completionJul 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
This is a randomized, duoble-blind (sport scientiest assistance/care assistance-outcome assessor), 6 arms prospective parallel design clinical trial. The older adults will be recruited from the Municipal Activity Centers for Older People located in Valencia and will be randomized in a prospective clinical trial study with a 6 parallel arms study design to a tubes or bands or water resistance training modalities performed at different intensities or a control group over a 32 weeks period.
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
320 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06618469
Sponsor's protocol ID
H1395923230221
Other IDs
OTR2015-140931NVES
Status last verified
Sep 2024
First submitted
18 Sep 2024
Last updated
1 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Elastic band-based resistance training program at high intensity (HI), Elastic band-based resistance training program at moderate-high intensity (MHI-bands) and Elastic band-based resistance training program at moderate intensity (MI) in people with Aging, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in DNA oxidative stress (time frame: Baseline and 16 weeks). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in